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First Worldwide Proficiency Study on Variable-Number
Tandem-Repeat Typing of Mycobacterium tuberculosis Complex
Strains
Jessica L. de Beer,a Kristin Kremer,b Csaba Ködmön,c Philip Supply,d,e Dick van Soolingen,a,f and
the Global Network for the Molecular Surveillance of Tuberculosis 2009
National Tuberculosis Reference Laboratory, Laboratory for Infectious Diseases and Perinatal Screening, Centre for Infectious Disease Control, National Institute for Public
Health and the Environment, Bilthoven, Netherlandsa; Tuberculosis and M/XDR-TB Programme, Division of Communicable Diseases, Health Security & Environment,
World Health Organization, Regional Office for Europe, Copenhagen, Denmarkb; Surveillance Unit, Tuberculosis Programme, European Centre for Disease Prevention and
Control, Stockholm, Swedenc; Center for Infection and Immunity of Lille, INSERM U1019-CNRS UMR 8204, Université Lille Nord de France and Institut Pasteur de Lille, Lille,
Franced; GenoScreen, Lille, Francee; and Radboud University Nijmegen Medical Centre, Dekkerswald, and Medical Microbiology, Nijmegen, Netherlandsf
Although variable-number tandem-repeat (VNTR) typing has gained recognition as the new standard for the DNA fingerprint-
ing ofMycobacterium tuberculosis complex (MTBC) isolates, external quality control programs have not yet been developed.
Therefore, we organized the first multicenter proficiency study on 24-locus VNTR typing. Sets of 30 DNAs of MTBC strains, in-
cluding 10 duplicate DNA samples, were distributed among 37 participating laboratories in 30 different countries worldwide.
Twenty-four laboratories used an in-house-adapted method with fragment sizing by gel electrophoresis or an automated DNA
analyzer, nine laboratories used a commercially available kit, and four laboratories used other methods. The intra- and inter-
laboratory reproducibilities of VNTR typing varied from 0% to 100%, with averages of 72% and 60%, respectively. Twenty of the
37 laboratories failed to amplify particular VNTR loci; if these missing results were ignored, the number of laboratories with
100% interlaboratory reproducibility increased from 1 to 5. The average interlaboratory reproducibility of VNTR typing using a
commercial kit was better (88%) than that of in-house-adapted methods using a DNA analyzer (70%) or gel electrophoresis
(50%). Eleven laboratories using in-house-adapted manual typing or automated typing scored inter- and intralaboratory repro-
ducibilities of 80% or higher, which suggests that these approaches can be used in a reliable way. In conclusion, this first multi-
center study has documented the worldwide quality of VNTR typing of MTBC strains and highlights the importance of interna-
tional quality control to improve genotyping in the future.
Since the early 1990s, the molecular typing of Mycobacteriumtuberculosis complex (MTBC) isolates has revealed important
novel insights into the epidemiology of tuberculosis (TB). In a
previous study on the intralaboratory reproducibility and dis-
criminatory power of typing methods for MTBC performed in
1999, the initial and widely applied standardized IS6110 restric-
tion fragment length polymorphism (RFLP) typing technique
(29) appeared to be highly reproducible and more discriminatory
than other typing techniques existing at that time (17). Therefore,
this technique was selected as the standard for the determination
of the molecular epidemiology of tuberculosis (17, 29, 30) and,
hence, for the study of the international transmission of
multidrug-resistant TB (MDR-TB) and extensively drug-resistant
TB (XDR-TB) in Europe (6, 7). However, IS6110 RFLP analysis is
technically demanding and time-consuming, and interlaboratory
comparisons of the generated banding patterns remained a chal-
lenge.
In recent years, variable-number tandem-repeat (VNTR) typ-
ing has become the new standard for the typing of MTBC strains
(26), because of its short turnaround time, simplified compari-
sons of digital results, and applicability to small amounts of DNA.
VNTR typing of MTBC isolates is a multiple-locus variant-repeat
analysis (MLVA) (20) based on the variation in the numbers of
DNA tandem repeats at multiple genomic loci. In its simplest
form, each target region is individually amplified by using primers
annealing to the flanks of the repeat-containing region. The am-
plicon sizes are determined by electrophoresis on agarose gels in
comparison to molecular size markers to deduce the number of
tandem-repeat units present at each locus (11, 19, 21, 22, 25, 28).
In an automated, high-throughput version, the target loci are am-
plified in multiplex PCRs by using fluorescently labeled primers,
and the amplicon sizes are determined by using a capillary elec-
trophoresis (CE)-based DNA analyzer (1, 4, 27). Although this
approach uses more expensive equipment and reagents, it has
been found to bemore efficient andmore accurate for the sizing of
amplicons (15) than themanual method. Another, less frequently
used method for amplicon size determinations is based on non-
denaturing high-performance liquid chromatography (non-
dHPLC) (8). In all instances, the final result of VNTR typing is a
numerical code that corresponds to the numbers of repeats in the
target locus and serves as a fingerprint of the respective MTBC
isolate. This simple format facilitates the efficient and reliable ex-
change and comparison of genotyping results both locally and
worldwide.
Although MLVA methods have been developed for many mi-
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croorganisms in recent years (20), studies regarding the reproduc-
ibility of these methods are limited. To our knowledge, the only
multilaboratory validation study performed was for MLVA of
Shiga toxin-producing Escherichia coliO157 (14). For MTBC iso-
lates, two small-scale initial quality control studies were previ-
ously performed at the Institut Pasteur, Lille, France (IPL), and at
the U.S. Centers for Disease Control and Prevention (CDC), At-
lanta, GA, demonstrating 100% intra- and interlaboratory repro-
ducibilities for both agarose gel and automated VNTR typing (24,
27). However, no international proficiency study has been orga-
nized since the standardization of the 24-locus VNTR typing
method for MTBC isolates in 2006 (26).
In 2009, the EuropeanCentre for Disease Prevention andCon-
trol (ECDC), Stockholm, Sweden, initiated a project, currently
outsourced to the Tuberculosis Reference Laboratory at the Na-
tional Institute for Public Health and the Environment (RIVM),
Bilthoven, The Netherlands, on the molecular surveillance of the
international transmission ofMDR-TB and XDR-TB in the Euro-
peanUnion. The participants of the project agreed to use 24-locus
VNTR typing as the standard for the typing of MTBC isolates. To
test the international intra- and interlaboratory reproducibilities
of VNTR typing, panels of 30 MTBC DNAs, including 10 blinded
duplicate DNAs, were sent to 18 of the European laboratories
participating in the MDR-TB molecular surveillance project and
to 19 other laboratories around the world. This report describes
the results of this proficiency study on the performance of VNTR
typing and provides recommendations to improve the reproduc-
ibility and comparability of the method.
MATERIALS AND METHODS
Study design. A test panel consisting of M. tuberculosis complex DNAs
was prepared at the RIVM and distributed among the 37 participating
laboratories. Laboratories were asked to perform VNTR typing as they
were accustomed to and to report the VNTR typing results to the RIVM in
a numerical format. The RIVM compared the results from each labora-
tory to those of the reference and reported the individual results to each of
the laboratories. In a questionnaire, laboratories were asked to supply
details on the VNTR typing method used.
Participants.Thirty-seven laboratories in 30 countries participated in
this quality control study. Twenty-three laboratories were located in Eu-
rope, including 18 participating within the framework of the ECDC-
funded Molecular Surveillance of M/XDR-TB in the European Union
project, outsourced to the RIVM. The remaining laboratories were lo-
cated in Asia (n 4), Oceania (n 1), Africa (n 1), and the Americas
(n 8) (including North America [n 5]).
Test panel. The quality control panel was comprised of 30 DNA sam-
ples of 20MTBC strains: 14M. tuberculosis strains (includingH37Rv) and
1 strain each of Mycobacterium bovis, M. bovis BCG, Mycobacterium mi-
croti, Mycobacterium canettii, Mycobacterium africanum, and Mycobacte-
rium pinnipedii. The selected strains have been extensively typed in
previous studies on mycobacterial interspersed repetitive-unit (MIRU)-
VNTR typing (27) and on comparisons of DNA typing methods (16, 17)
and represent the phylogenetic variety ofM. tuberculosis complex isolates
and allelic ranges of VNTR markers (27). Ten blinded duplicate DNA
samples of MTBC strains were included: seven M. tuberculosis strains
(including H37Rv), one M. microti strain, one M. africanum strain, and
oneM. bovis BCG strain.
DNAwas extracted as previously described (17). TheDNA concentra-
tion was measured with the Nanodrop-1000 system (Thermo Scientific,
Wilmington, DE). For the preparation of all 37 test panels, the DNA
samples were diluted to a final concentration of 100 ng/l and divided
over 37 batches. The test panels were stored at 20°C and shipped at
room temperature by courier service. Laboratories were asked to dilute
the samples by adding molecular-grade water to achieve a final concen-
tration of 10 ng/l.
Reference typing results. The reference results were obtained at the
RIVM by applying both an in-house VNTR typing method and a com-
mercial kit for VNTR typing (GenoScreen, Lille, France). The in-house
VNTRmethod is based on the protocol of theMIRU-VNTR typing man-
ual (publicly available from the MIRU-VNTRplus website [www.miru
-vntrplus.org]) as originally described by Supply et al. (26), with the fol-
lowing modifications: the amount of DNA polymerase was increased to
0.75 units per multiplex PCR, and the initial concentration of labeled
primers for locus 2165 and locus 2163b was increased to 8 M. For both
methods, the amplicon sizeswere determined by using the automatedABI
3730 DNA analyzer (Applied Biosystems, CA). The results of both meth-
ods were in complete agreement and were also in complete agreement
with results previously obtained for these samples (16, 17, 27). Finally, one
of the strains included in the panel was M. tuberculosis control strain
H37Rv, thewhole genome of whichwas sequenced previously (3), and the
genome-derived numbers of repeats matched exactly with those found by
VNTR typing at the RIVM.
Data analysis. The results of the participating laboratories were com-
pared to those of the reference laboratory, the RIVM, to determine the
inter- and intralaboratory reproducibilities. To determine the error rate
per VNTR locus, systematic errors were excluded because they would
have a high impact on this error rate. The assumption for the cutoff value
for systematic errors was 20 errors for an individual VNTR locus with
identical differences compared to the reference results.
The conditional chi-square test was used to test the homogeneity of
the distribution of errors within a group of participants using the same
VNTRmethod. Assuming that the number of errors in a laboratory has a
Poisson distribution and that this distribution is similar for all laborato-
ries, the conditional distribution of the errors among laboratories given
the total number of errors is multinomial, with the same probability for
each participating laboratory. Thus, the null hypothesis can be tested by
means of the conditional, exact chi-square test for goodness of fit. A
mixed-effects Poisson model was used to extricate the potential differ-
ences between the groups of methods from the evident effect of the labo-
ratory on the number of errors.
RESULTS
The DNA test panel was subjected to VNTR typing by 37 labora-
tories in 30 countries: 34 laboratories analyzed 24 loci (26), 2
laboratories analyzed a subset of 15 loci (26), and 1 laboratory
typed 14 loci. The laboratories could be divided into four groups
on the basis of the VNTR typing method used: (i) 15 laboratories
used an in-house PCRmethod and determined amplicon sizes by
using agarose gel electrophoresis, (ii) 9 laboratories used an in-
house PCRmethod and determined amplicon sizes by using a CE
DNA analyzer, (iii) 9 laboratories used a commercial kit and a CE
DNA analyzer, and (iv) 4 laboratories used other methods (Table
1). The alternative methods used by group 4 included the use of
PCR reagents from Tiangen Biotech (Beijing, China), the perfor-
mance of VNTR typing based onmethods described previously by
Murase et al. (23), adaptations of the VNTR typing method based
on multiple previously reported methods (2, 12, 18), and the use
of the TransenomicWave high-performance liquid chromatogra-
phy system (Transenomic Inc., Omaha, NE) (8).
The number of missing results as a consequence of an ampli-
fication failure gives an indication of the typeability of the differ-
entmethods applied. The percentages of complete VNTRpatterns
reported by the laboratories did not differ significantly between
the various methods used; these percentages were 97% for labo-
ratories using an agarose gel electrophoresis-based in-house
method, 92% for laboratories using a DNA analyzer-based in-
Reproducibility of VNTR Typing
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housemethod, and 96% for laboratories using the commercial kit
and aDNA analyzer (Table 1). In contrast, the percentage of com-
plete VNTR patterns was lower for those laboratories using other
methods, 79%.
If the typeability is calculated at the locus level, i.e., the number
of results obtained as a percentage of the total number of loci
typed in the VNTR typing of the complete set of samples, the locus
typeability score is obtained. The typeability score for the labora-
tories that used an in-house PCRmethod and detected the ampli-
con sizes by gel electrophoresis was 99.8%. For the laboratories in
which amplicon sizes were analyzed on a DNA analyzer, the in-
house approach and the commercial approach yielded nearly the
same results, 99.6% and 99.5%, respectively.
Interlaboratory reproducibility. To determine the interlabo-
ratory reproducibility of VNTR typing, the percentages of the 30
DNA samples for which the numbers of repeats were correctly
scored for all loci typed in comparison to the reference laboratory
results were calculated for each of the participating laboratories
(Fig. 1). Apart from the reference laboratory, only one laboratory
yielded a complete and fully correct 24-locus VNTR typing result
for all 30 samples and thus had inter- and intralaboratory repro-
ducibilities of 100%. Eleven laboratories had an interlaboratory
reproducibility score of 90% or higher, six had a score between
80% and 90%, five had a score between 70% and 80%, and four
had a score between 20% and 60%. Nine of the 37 laboratories
reported incorrect results for all 30 samples.
The level of interlaboratory reproducibility was in part de-
creased by the occurrence of incomplete VNTR patterns, i.e.,
missing results for one or more loci in at least one sample.
Twenty laboratories reported such incompleteVNTRpatterns,
with missing results for 1 to 9 loci of the set of 24 for one or more
samples of the panel. If missing results were not interpreted as
incorrect results, the individual interlaboratory reproducibility of
11 laboratories increased up to 40% (mean, 12%; range, 3% to
40%), and the total number of laboratories with a 100% interlabo-
ratory reproducibility increased from 1 to 5 (Fig. 1).
Intralaboratory reproducibility. The intralaboratory repro-
ducibility of VNTR typing was determined for each laboratory by
comparing the patterns reported for the 10 duplicate DNA sam-
ples (Fig. 2). Incomplete patterns were included in the calculation;
i.e., missing results for a particular locus for both samples of a
duplicate contributed positively to the intralaboratory reproduc-
ibility percentage, while a missing result for only one sample of a
duplicate contributed negatively to the intralaboratory reproduc-
ibility score. Eleven laboratories (reference excluded) had identi-
cal typing results for all 10 duplicated samples and thus had an
intralaboratory reproducibility of 100%. Twelve laboratories had
an intralaboratory reproducibility of 80% to 90%, and four had an
intralaboratory reproducibility of 60% to 70%. Seven laboratories
reported identical typing results for less than 5 (50%) of the
TABLE 1 Methods used to perform 24-locus VNTR typing of
M. tuberculosis complex and average inter- and
intralaboratory reproducibilitiesa
Method for VNTR
typing
No. of
participating
laboratories
Avg % reproducibility (range)
Typeability
(%)Interlaboratory Intralaboratory
In-house PCRb
Sizing by gel
electrophoresis
15 50 (0–77) 74 (0–100) 97
Sizing by DNA
analyzer
9 70 (0–100) 73 (10–100) 92
GenoScreen
commercial kit
Sizing by DNA
analyzer
9 88 (50–100) 82 (10–100) 96
Other 4 5 (0–20) 38 (0–60) 79
Total for all
methods
37 60 72 93
a Data include missing results as mistakes. The typeability of each method is the average
percentage of obtained complete VNTR pattern results for the 30 samples of the panel.
b Based on or adapted from methods described previously by Supply et al. (26).
FIG 1 Interlaboratory reproducibility of VNTR typing of 30 M. tuberculosis complex DNA samples scored by 36 participating laboratories and the reference
laboratory. The black bars represent the reproducibility on the basis of VNTR patterns that were completely identical to those obtained by the reference
laboratory (laboratory 37). The gray bars represent the cumulative reproducibility when VNTR patterns that containedmissing results were included but which
were identical to those obtained by the reference laboratory when not considering the loci with missing results. Most laboratories used 24-locus VNTR typing,
and three laboratories used either 14 loci (#) or 15 loci () for typing.
de Beer et al.
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duplicated samples, including two laboratories that had different
VNTR patterns for all 10 duplicated samples.
Analysis of incorrect results. Deviations from the standard
allele-calling system, i.e., the translation of PCR product sizes into
repeat numbers, were themain cause of systematic errors. System-
atic errors were identified for 17 of the 24 VNTR loci, reported by
1 to 5 laboratories for each of these loci. Among the nine labora-
tories that had an incorrect analysis of all 30 samples, and thus had
0% interlaboratory reproducibility, six had incorrect analyses
caused by systematic errors. The other three laboratories reported
random errors.
In two laboratories, incidents of erroneous sample exchange
were detected. One laboratory exchanged two samples, and an-
other laboratory tested one sample twice, leaving another sample
untested. The errors due to sample exchange were excluded from
the error analysis by VNTR locus, as were the complete numbers
of errors of two laboratories that produced an extremely high
number of errors (responsible for 24% and 28% of the total not-
typed or incorrectly typed samples, after the exclusion of the sys-
tematic errors). The highest number of errors was identified for
the locus at genomic position 4052, which was typed incorrectly
54 times (15% of all the errors, after the exclusion of the errors
mentioned above). The error rate for the other VNTR loci ranged
from 0% (n 0) for the locus at position 154 to 11.5% (n 42)
for the locus at position 4156 (Fig. 3).
Reproducibility by VNTR locus. When the intra- and inter-
laboratory reproducibilities were analyzed at the level of individ-
ual loci instead of the complete 24-locus VNTR patterns, the
average scores for inter- and intralaboratory reproducibility in-
creased from 60% to 92% and from 72% to 96%, respectively.
To determine the extent of typing errors in the 24-locus VNTR
patterns of the incorrectly typed samples, the results of the erro-
neous sample substitutions in two laboratories and the missing
loci in the results were excluded from the calculation; this left 31
laboratories for analysis. The average number of incorrect loci per
strain was calculated for the samples with incorrect VNTR pat-
terns. Thirteen of the participating laboratories had an average of
one incorrect locus, which means that for the incorrectly typed
samples, there was on average one locus that was different com-
pared to the reference. Six laboratories had on average between 1
and 2 incorrectly analyzed loci, seven laboratories had between 2
and 4 incorrectly analyzed loci, and five laboratories had on aver-
age more than 4 incorrectly analyzed loci. The latter laboratories,
whichwere identified as the laboratories with the highest numbers
of errors per strain, all made systematic errors.
Reproducibility and typeability by method. The different
methodologies applied in the laboratories impacted the typeabil-
ity and the intra- and interlaboratory reproducibilities (Table 1).
The 15 participants that applied the in-housemethod with ampli-
con sizing by gel electrophoresis had average inter- and intralabo-
ratory reproducibilities of 50% and 74%, respectively, and the 9
laboratories that used an in-house PCR method and determined
amplicon sizes with a DNA analyzer had scores of 70% and 73%,
respectively. The best results were obtained by the 9 participants
who used a commercial kit and a DNA analyzer, 88% and 82%,
respectively. However, the conditional chi-square test showed
that none of the groups was homogeneous (P values of 0.001),
and certain laboratories hadmanymore errors than other labora-
tories within the same group, which raises the question of whether
these differences in reproducibility are significant or even mean-
ingful. The interlaboratory reproducibility of the methodologies
was influenced by systematic errors, which were reported by five
laboratories that used the in-house PCR method with amplicon
sizing by gel electrophoresis, by a single laboratory that used the
in-house method and determination of amplicon sizes with a
DNA analyzer, and by three laboratories that used othermethods.
In contrast, systematic errors were not detected for the laborato-
ries that used the commercial 24-locus VNTR typing kit.
The typeability score represents the ability of a method to de-
liver a typing result, without considering the quality of this result.
The typeability score for the complete VNTR patterns was higher
for laboratories that applied the in-house method with amplicon
sizing by gel electrophoresis and the laboratories that used the
commercial VNTR kit; with these approaches, on average, 97%
FIG 2 Intralaboratory reproducibility of VNTR typing of 10 duplicatedDNA samples ofM. tuberculosis scored by 36 participating laboratories and the reference
laboratory (laboratory 37). The laboratory numbers correspond to those shown in Fig. 1. Most laboratories used 24-locus VNTR typing, and three laboratories
used either 14 loci (#) or 15 loci () for typing.
Reproducibility of VNTR Typing
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and 96% of all samples, respectively, yielded a complete typing
pattern. Laboratories that used an in-house PCR method and de-
termined amplicon sizes with a DNA analyzer scored 92%, and
laboratories that used other methods scored only 79%.
DISCUSSION
This is the first multicenter proficiency study of 24-locus VNTR
typing ofM. tuberculosis complex strains after its standardization
in 2006. Initial tests conducted early in the development of this
technique, with bilaterally exchanged blinded reference samples,
demonstrated that VNTR typing was highly reproducible for a
limited number of experienced laboratories at both the intra- and
interlaboratory levels (5, 16, 17, 24, 27). However, our study
showed that many laboratories were not able to perform 24-locus
VNTR typing in agreement with the reference. In fact, our study
demonstrates that the reproducibility of 24-locus VNTR typing as
it is currently applied is limited, with an average interlaboratory
reproducibility of 60% (range, 0% to 100%) and an average in-
tralaboratory reproducibility of 72% (range, 0% to 100%). Errors
were caused by systematic deviations from the standard allele-
calling system (i.e., rules for translating PCR product sizes into
repeat numbers), the challenging amplification of some VNTR
loci, and nontechnical issues such as sample exchange and incor-
rect software use. Appropriate analysis, corrections of the prob-
lems encountered, good laboratory practice, and further stan-
dardization are essential for the reliable use of this technique to
study themolecular epidemiology of TB at local and international
levels.
Nontechnical errors. Two incidents of sample exchanges re-
duced the inter- and intralaboratory reproducibility scores for the
two respective laboratories substantially. Mistakes also occurred
whilemanaging the results with the frequently used Excel software
program (Microsoft Co., Redmond,WA). Systematic labeling and
handling of samples during all stages of the VNTR typing tech-
nique as well as schemes for datamanagement should be incorpo-
rated into protocols to minimize these nontechnical errors.
Allele-calling errors. Systematic deviations from the standard
allele-calling systemwere the cause of 51% of all errors (including
themissing results as systematic errors on the locus level) detected
in this study, and this has significantly reduced the interlaboratory
reproducibility measured in this proficiency study. The use of al-
ternative PCR primer sequences by some groups (e.g., as de-
scribed previously by Le Fleche et al. [19]) can also affect allele
calling based on amplicon sizes. The use of nonstandard allele-
calling systems is a general issue in VNTR typing. This problem
could be solved by the standardization of the allele calling tables
between user laboratories. The use of standard allele calling tables
and primers (e.g., publicly available from the MIRU-VNTRplus
website [www.miru-vntrplus.org]) establishes an unequivocal
correspondence between an amplicon size calculated by electro-
phoresis on agarose gels and a conventional repeat unit number
for these loci. The calibration of CE-based DNA analyzers with
allelic ladders included in the commercial kit or the use of refer-
ence samples enables the integration of the standard allele calling
information for subsequent semiautomated allele-calling special-
ized software. In addition, both calibration methods correct CE-
specific effects, i.e., determine the relative migration between the
size standard and the PCR products, depending on the VNTR loci
and alleles, and differ by polymers used for capillary electropho-
resis and between instruments (1, 26). To ensure compliance with
the standard allele-calling system, the inclusion of reference
strains in each run enables first-line quality control of amplicon
size interpretations.
VNTR typingmethod. The highest reproducibility on average
was obtained by the participants using the CE-based commercial
kit, followed by laboratories using in-house-adapted CE-based
FIG 3 Distribution of detected errors by locus in the 24-locus VNTR panel calculated on the basis of the results of typing of 30 M. tuberculosis complex DNA
samples by 35 laboratories (excluding laboratories 2 and 5, the systematic errors, and the two incidents of sample exchange described in detail in the text). Among
the errors, wrong results and missing results were distinguished.
de Beer et al.
666 jcm.asm.org Journal of Clinical Microbiology
 o
n
 February 16, 2012 by RIVM
http://jcm.asm.org/
D
ow
nloaded from
 
typing, those using gel-based analysis, and, lastly, those using
othermethods. Analysis of amplicon sizes by gel electrophoresis is
inexpensive and simple but requires a high degree of organization
and good laboratory practices, as each sample requires the indi-
vidual amplification of 24 loci, separate analysis on gels, and, fi-
nally, manual interpretation and database management. Another
factor that presumably negatively influenced the performances of
the gel-based VNTR typing method is the lower level of accuracy
of allele sizing on gels, especially for larger PCR fragments. This
factor can partly account for the larger proportion of (single- or
more-repeat) errors observed for the locus at position 4052, hav-
ing the largest repeat unit size (111 bp [26]) and therefore gener-
ating some of the largest allele sizes among the 24 loci (approxi-
mately 700 to 1,000 bp in this panel). Six laboratories were able to
achieve an interlaboratory reproducibility of 80% or higher by
using manual typing, suggesting that the challenges are not inher-
ent to the VNTR typing method and can be addressed by use of
appropriate quality control and quality assurance measures.
However, the conditional chi-square test showed that none of
the groups of methods was homogeneous (P values of 0.001).
Since each laboratory belonged to a single group of methods, the
observed differences in reproducibility could very well be due to
the laboratories. As an attempt to extricate the potential effects of
methods from the effects of the laboratory, we have fitted amixed-
effects Poissonmodel to the data, in which the number of errors is
modeled in terms of method and locus and each laboratory con-
tributes a random effect. The model’s estimates yielded no signif-
icant effect of the method (P values of 0.179 and 0.362 for the
effects of both in-house methods over the reference commercial
method) and suggest that the differences between the three meth-
ods are due mainly to the laboratories using them. In particular,
the estimates of the random effects reflect the excessive numbers
of errors observed for certain laboratories very well. Note, how-
ever, that this lack of evidence for differences between the choices
of method may, as usual, be due to the actual differences being
relatively small and, hence, should not be taken as a positive state-
ment of “no difference.”
The typeability, i.e., the ability to report a complete VNTR
pattern, was slightly better in laboratories that used gel electro-
phoresis for the detection of amplicon sizes than in those that used
a CE DNA analyzer. This may be explained by differences in the
PCR protocols used to amplify the VNTR loci. The in-house
methods with gel electrophoresis detection used monoplex PCRs,
which have an advantage over multiplex PCRs used in combina-
tion with a CE DNA analyzer. For multiplex PCR systems, some
loci may not be amplified as efficiently as others because of ampli-
fication competition; the amplification of relatively large targets in
combination with relatively small targets can be particularly chal-
lenging and can be the cause of unamplified loci. The use ofmono-
plex PCRs with the VNTR typingmethod will improve the ampli-
fication efficiency. Therefore, we recommend that laboratories
that use CE DNA analyzers to estimate fragment sizes should re-
peat the amplification of a particular locus with a monoplex PCR
in cases ofmissing loci to either determine the size of the amplicon
or confirm the missing results.
The typeability of VNTR typing, as measured in this study, was
negatively influenced by the incorporation of anM. canettii isolate
in theDNApanel. For instance, 15 of 37 participating laboratories
were not able to amplify the VNTR locus at position 4052 of the
respective DNA sample. This can be explained by the presence of
single nucleotide polymorphisms (SNPs) in the primer regions of
M. canettii isolates (P. Supply et al., unpublished data).M. canettii
isolates display exceptionally large and thereforemore challenging
alleles in other loci (e.g., VNTR loci at positions 802 and 2165 are
also associated with typeability and/or reproducibility problems)
(9, 10, 13). AsM. canettii strains are found very rarely outside East
Africa (9, 10, 31), the problems regarding VNTR typing are not
likely to have an impact on the monitoring of the transmission of
TB in other areas of the world.
If considered at the level of individual loci instead of complete
24-locus genotypes, the average inter- and intralaboratory repro-
ducibilities increased from 60% to 92% and from 72% to 96%,
respectively. However, any mistake in a single locus will finally
generate an incorrect 24-locus VNTR typing pattern. Translated
into the main objective of typing, namely, the accurate DNA fin-
gerprinting of M. tuberculosis isolates for the detection of TB
transmission and bacterial population diversity in a certain area,
such individual-locusmistakes would lead to the incorrect confir-
mation or exclusion of an epidemiological link. Therefore, from a
public health perspective, reproducibilitymust thus be considered
at the full 24-locus genotype level.
The results of this study cast doubt on the validity of some of
the data for VNTR typing reported previously. Therefore, we rec-
ommend that each laboratory that obtained unsatisfactory results
in this proficiency study should retype part of their previously
typed isolates with an improved procedure to evaluate the reliabil-
ity of earlier studies. Moreover, this study underlines the impor-
tance of first-, second-, and third-line quality control of DNA
fingerprint methods in general and of MLVA methods in partic-
ular. The very low reproducibility scores for some of the labora-
tories in our study of the reproducibility of VNTR typing of M.
tuberculosis complex isolates should prompt the development of
proficiency schemes for MLVA of other microorganisms (20).
In summary, the results of this proficiency study suggest that
the use of the commercial kit will provide optimal levels of VNTR
typing reproducibility and typeability. This evaluation proved
useful in detecting systematic and incidental errors that reduced
the reproducibility of in-house-adapted typing. In fact, 11 labora-
tories that used in-house-adapted manual typing or automated
typing scored inter- and intralaboratory reproducibilities of 80%
or higher, which suggests that these approaches can be used in a
reliable way, provided that minimal standard conditions are fol-
lowed.
Based on the information collected in this study, the main ob-
servation is the importance of incorporating appropriate quality
control and quality assurance measures into protocols for geno-
typing methods. Continuous improvements of protocols, based
on experiences shared by the laboratories in the typing network,
will be made available at the RIVM Tuberculosis Reference Labo-
ratorywebsite (www.tuberculosis.rivm.nl). After the introduction
of the suggested improvement in the methodology, it is expected
that VNTR typing will becomemore reliable inmost laboratories.
To investigate this, a second round of proficiency studies will be
arranged shortly.
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